🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Georgia › Atlanta

Acute Myeloid Leukemia clinical trials in Atlanta, GA

28 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RecruitingPhase 1
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06484062

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

RecruitingPhase 1
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Up to age 21 · All sexes · Updated Sep 23, 2026 · NCT07012044

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
  • Emory Winship Cancer Institute, Atlanta
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecruitingPhase 2
  • Winship Cancer Institute - Emory University, Atlanta
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

RecruitingPhase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Ages 1 to 25 · All sexes · Updated Sep 4, 2026 · NCT07022678

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Atlanta VA Medical Center, Decatur · 6 mi away
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

RecruitingPhase 3
  • US-Atlanta GA-EMORY, Atlanta
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • US-Atlanta GA-EMORY, Atlanta
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07223814

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · All sexes · Updated Aug 24, 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RecruitingPhase 1
  • Children's Healthcare of Atlanta, Atlanta
Ages 1 to 30 · All sexes · Updated Aug 3, 2026 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

RecruitingPhase 1Healthy volunteers welcome
  • Northside Hospital, Atlanta
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RecruitingPhase 3
  • Emory University - Winship Cancer Institute (WCI), Atlanta
Ages 18 to 75 · All sexes · Updated Jul 17, 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

RecruitingPhase 1/2
  • Emory Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT04068597

Ivosidenib as Post-HSCT Maintenance for AML

RecruitingPhase 2
  • Emory University Hospital, Atlanta
Ages 18 to 75 · All sexes · Updated Jun 18, 2026 · NCT06707493

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Winship Cancer Institute / Emory University, Atlanta
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RecruitingPhase 2/3
  • University of Emory - Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317

Pilot Imaging Study of Leukemia

RecruitingPhase 1
  • Emory University, Atlanta
Ages 4 to 80 · All sexes · Updated Apr 23, 2026 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

RecruitingPhase 2Healthy volunteers welcome
  • Northside Hospital, Atlanta
Ages 18 to 75 · All sexes · Updated Mar 10, 2026 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

RecruitingPhase 1
  • Emory University Hospital, Atlanta
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

RecruitingPhase 1
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
Ages 12 and older · All sexes · Updated Jan 8, 2026 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Blood and Marrow Transplant Group of Georgia, Atlanta
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RecruitingHealthy volunteers welcome
  • Emory University, Atlanta
Ages 18 to 120 · All sexes · Updated Jul 25, 2025 · NCT05237258

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.